| __timestamp | Bausch Health Companies Inc. | Iovance Biotherapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 246000000 | 2704597 |
| Thursday, January 1, 2015 | 582800000 | 15470000 |
| Friday, January 1, 2016 | 455000000 | 28037000 |
| Sunday, January 1, 2017 | 366000000 | 71615000 |
| Monday, January 1, 2018 | 414000000 | 99828000 |
| Tuesday, January 1, 2019 | 471000000 | 166023000 |
| Wednesday, January 1, 2020 | 452000000 | 201727000 |
| Friday, January 1, 2021 | 465000000 | 259039000 |
| Saturday, January 1, 2022 | 529000000 | 294781000 |
| Sunday, January 1, 2023 | 604000000 | 344077000 |
Unlocking the unknown
In the ever-evolving landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Bausch Health Companies Inc. and Iovance Biotherapeutics, Inc. have demonstrated contrasting trajectories in their R&D investments.
Bausch Health, a stalwart in the industry, has consistently increased its R&D budget, culminating in a 145% rise from 2014 to 2023. This growth underscores their strategic focus on expanding their product pipeline. In contrast, Iovance Biotherapeutics, a rising star, has shown a staggering 12,600% increase in R&D spending over the same period, reflecting their aggressive push to develop cutting-edge therapies.
This data highlights the dynamic nature of the biotech sector, where established giants and nimble newcomers alike are investing heavily in the future of healthcare.
Research and Development: Comparing Key Metrics for AstraZeneca PLC and Iovance Biotherapeutics, Inc.
R&D Spending Showdown: Zoetis Inc. vs Iovance Biotherapeutics, Inc.
Research and Development Investment: Biogen Inc. vs Iovance Biotherapeutics, Inc.
Neurocrine Biosciences, Inc. vs Bausch Health Companies Inc.: Strategic Focus on R&D Spending
Pharming Group N.V. or Bausch Health Companies Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Grifols, S.A. and Bausch Health Companies Inc.
Who Prioritizes Innovation? R&D Spending Compared for ADMA Biologics, Inc. and Bausch Health Companies Inc.
Bausch Health Companies Inc. vs Iovance Biotherapeutics, Inc.: SG&A Expense Trends
R&D Spending Showdown: Amicus Therapeutics, Inc. vs Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. or MannKind Corporation: Who Invests More in Innovation?
Research and Development Investment: Iovance Biotherapeutics, Inc. vs Taro Pharmaceutical Industries Ltd.
Iovance Biotherapeutics, Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?